Register here for this free webinar.
Most gut health solutions focus on adding beneficial microbes. Bacteriophages take a different approach by selectively targeting specific unwanted bacteria while leaving beneficial microbes intact.
Join ADM to explore the science behind this emerging microbiome category, how bacteriophages differ from probiotics, prebiotics, and postbiotics, and why targeted microbiome management is generating growing interest among researchers, brands, and consumers.
You'll also gain insights into consumer perceptions and market opportunities for this evolving area of gut health.
With:
Aouatef Bellamine, Ph.D.
Scientific Marketing Director, Health and Wellness
ADM Nutrition
Dr. Aouatef Bellamine is a distinguished Clinical Scientist and scientific leader with over two decades of expertise spanning pharmaceuticals, human nutrition, and animal health. As Scientific Marketing Director at ADM Health and Wellness, she bridges cutting-edge technologies with commercial innovation and consumer insights, drives scientific strategy, portfolio support, and clinical substantiation across both human and pet nutrition divisions.
Prior to ADM, Dr. Bellamine spent over a decade as a leading R&D figure in Lonza’s Nutrition business, where she directed clinical development, technology acquisitions, and new product launches. Her early career in pharmaceuticals at Bristol-Myers Squibb included pivotal contributions to metabolic disease medical affairs—most notably supporting major diabetes drug launches and evaluating cardiovascular outcomes in the landmark SAVOR trial—as well as leading safety programs on lipodystrophy associated with HIV therapies.
A pioneer in cytochrome P450 research, Dr. Bellamine was the first to purify and characterize the CYP51, a lipid-metabolizing enzyme in Mycobacterium tuberculosis. She earned her Ph.D. in Toxicology with honors from Sorbonne University and completed research at Vanderbilt University Medical Center. An accomplished author of over 40 peer-reviewed publications and 10 global patents, she frequently serves as a keynote speaker and scientific advisory board member. She is an active member of leading organizations including AAAS, ASBMB, ASN, CRN, ADA, and SOT.
Vaughn DuBow
Senior Director, Marketing, Human Health and Wellness
ADM Nutrition
Vaughn DuBow is Senior Director of Marketing for Human Health & Wellness at ADM, where he leads strategic marketing initiatives across North America with a focus on microbiome solutions, dietary supplements, and functional nutrition. With more than 15 years of experience in the health and wellness industry, Vaughn works closely with commercial, R&D, and scientific teams to translate emerging science into meaningful consumer solutions and commercial growth opportunities.
His passion lies in bringing next-generation ingredients—including probiotics, postbiotics, bacteriophages, and other precision microbiome technologies—to market through innovative product concepts, education, and thought leadership. Vaughn is a frequent speaker on microbiome innovation and enjoys helping brands understand how cutting-edge science can become successful consumer products.
Additional speaker to be announced
Sponsored by ADM, part of the Council for Responsible Nutrition's Science-based Virtual Tradeshow Series.